Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Identification of carboxypeptidase X (CPX)-1 as a positive regulator of adipogenesis.

Kim YH, Barclay JL, He J, Luo X, O'Neill HM, Keshvari S, Webster JA, Ng C, Hutley LJ, Prins JB, Whitehead JP.

FASEB J. 2016 Jul;30(7):2528-40. doi: 10.1096/fj.201500107R. Epub 2016 Mar 22.

PMID:
27006448
2.

Community Oncology Medical Homes: Physician-Driven Change to Improve Patient Care and Reduce Costs.

Waters TM, Webster JA, Stevens LA, Li T, Kaplan CM, Graetz I, McAneny BL.

J Oncol Pract. 2015 Nov;11(6):462-7. doi: 10.1200/JOP.2015.005256. Epub 2015 Jul 28.

3.

Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies.

Goddard KA, Whitlock EP, Berg JS, Williams MS, Webber EM, Webster JA, Lin JS, Schrader KA, Campos-Outcalt D, Offit K, Feigelson HS, Hollombe C.

Genet Med. 2013 Sep;15(9):721-8. doi: 10.1038/gim.2013.37. Epub 2013 Apr 4.

4.

Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms.

Thomas EC, Gunter JH, Webster JA, Schieber NL, Oorschot V, Parton RG, Whitehead JP.

PLoS One. 2012;7(12):e51096. doi: 10.1371/journal.pone.0051096. Epub 2012 Dec 7.

5.

Utilization of HER2 genetic testing in a multi-institutional observational study.

Goddard KA, Bowles EJ, Feigelson HS, Habel LA, Alford SH, McCarty CA, Nekhlyudov L, Onitilo AA, Rahm AK, Webster JA.

Am J Manag Care. 2012 Nov;18(11):704-12.

6.

Identification of BMP and activin membrane-bound inhibitor (BAMBI) as a potent negative regulator of adipogenesis and modulator of autocrine/paracrine adipogenic factors.

Luo X, Hutley LJ, Webster JA, Kim YH, Liu DF, Newell FS, Widberg CH, Bachmann A, Turner N, Schmitz-Peiffer C, Prins JB, Yang GS, Whitehead JP.

Diabetes. 2012 Jan;61(1):124-36. doi: 10.2337/db11-0998.

7.

Acupuncture and chiropractic care for chronic pain in an integrated health plan: a mixed methods study.

DeBar LL, Elder C, Ritenbaugh C, Aickin M, Deyo R, Meenan R, Dickerson J, Webster JA, Jo Yarborough B.

BMC Complement Altern Med. 2011 Nov 25;11:118. doi: 10.1186/1472-6882-11-118.

8.

Loss-of-function mutations of ILDR1 cause autosomal-recessive hearing impairment DFNB42.

Borck G, Ur Rehman A, Lee K, Pogoda HM, Kakar N, von Ameln S, Grillet N, Hildebrand MS, Ahmed ZM, Nürnberg G, Ansar M, Basit S, Javed Q, Morell RJ, Nasreen N, Shearer AE, Ahmad A, Kahrizi K, Shaikh RS, Ali RA, Khan SN, Goebel I, Meyer NC, Kimberling WJ, Webster JA, Stephan DA, Schiller MR, Bahlo M, Najmabadi H, Gillespie PG, Nürnberg P, Wollnik B, Riazuddin S, Smith RJ, Ahmad W, Müller U, Hammerschmidt M, Friedman TB, Riazuddin S, Leal SM, Ahmad J, Kubisch C.

Am J Hum Genet. 2011 Feb 11;88(2):127-37. doi: 10.1016/j.ajhg.2010.12.011. Epub 2011 Jan 20.

9.

Mutations in TMC1 are a common cause of DFNB7/11 hearing loss in the Iranian population.

Hildebrand MS, Kahrizi K, Bromhead CJ, Shearer AE, Webster JA, Khodaei H, Abtahi R, Bazazzadegan N, Babanejad M, Nikzat N, Kimberling WJ, Stephan D, Huygen PL, Bahlo M, Smith RJ, Najmabadi H.

Ann Otol Rhinol Laryngol. 2010 Dec;119(12):830-5.

10.

A novel mutation in COCH-implications for genotype-phenotype correlations in DFNA9 hearing loss.

Hildebrand MS, Gandolfo L, Shearer AE, Webster JA, Jensen M, Kimberling WJ, Stephan D, Huygen PL, Smith RJ, Bahlo M.

Laryngoscope. 2010 Dec;120(12):2489-93. doi: 10.1002/lary.21159.

11.

Variations in stromal signatures in breast and colorectal cancer metastases.

Webster JA, Beck AH, Sharma M, Espinosa I, Weigelt B, Schreuder M, Montgomery KD, Jensen KC, van de Rijn M, West R.

J Pathol. 2010 Oct;222(2):158-65. doi: 10.1002/path.2738.

12.

Variable hearing impairment in a DFNB2 family with a novel MYO7A missense mutation.

Hildebrand MS, Thorne NP, Bromhead CJ, Kahrizi K, Webster JA, Fattahi Z, Bataejad M, Kimberling WJ, Stephan D, Najmabadi H, Bahlo M, Smith RJ.

Clin Genet. 2010 Jun;77(6):563-71. doi: 10.1111/j.1399-0004.2009.01344.x. Epub 2010 Feb 4.

13.

Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.

Sharma M, Beck AH, Webster JA, Espinosa I, Montgomery K, Varma S, van de Rijn M, Jensen KC, West RB.

Breast Cancer Res Treat. 2010 Sep;123(2):397-404. doi: 10.1007/s10549-009-0654-0. Epub 2009 Dec 1.

14.

Mutations in LOXHD1, an evolutionarily conserved stereociliary protein, disrupt hair cell function in mice and cause progressive hearing loss in humans.

Grillet N, Schwander M, Hildebrand MS, Sczaniecka A, Kolatkar A, Velasco J, Webster JA, Kahrizi K, Najmabadi H, Kimberling WJ, Stephan D, Bahlo M, Wiltshire T, Tarantino LM, Kuhn P, Smith RJ, Müller U.

Am J Hum Genet. 2009 Sep;85(3):328-37. doi: 10.1016/j.ajhg.2009.07.017.

15.

Genetic control of human brain transcript expression in Alzheimer disease.

Webster JA, Gibbs JR, Clarke J, Ray M, Zhang W, Holmans P, Rohrer K, Zhao A, Marlowe L, Kaleem M, McCorquodale DS 3rd, Cuello C, Leung D, Bryden L, Nath P, Zismann VL, Joshipura K, Huentelman MJ, Hu-Lince D, Coon KD, Craig DW, Pearson JV; NACC-Neuropathology Group, Heward CB, Reiman EM, Stephan D, Hardy J, Myers AJ.

Am J Hum Genet. 2009 Apr;84(4):445-58. doi: 10.1016/j.ajhg.2009.03.011.

16.

Mutations in the first MyTH4 domain of MYO15A are a common cause of DFNB3 hearing loss.

Shearer AE, Hildebrand MS, Webster JA, Kahrizi K, Meyer NC, Jalalvand K, Arzhanginy S, Kimberling WJ, Stephan D, Bahlo M, Smith RJ, Najmabadi H.

Laryngoscope. 2009 Apr;119(4):727-33. doi: 10.1002/lary.20116.

17.

A novel splice site mutation in the RDX gene causes DFNB24 hearing loss in an Iranian family.

Shearer AE, Hildebrand MS, Bromhead CJ, Kahrizi K, Webster JA, Azadeh B, Kimberling WJ, Anousheh A, Nazeri A, Stephan D, Najmabadi H, Smith RJ, Bahlo M.

Am J Med Genet A. 2009 Mar;149A(3):555-8. doi: 10.1002/ajmg.a.32670. No abstract available.

18.

Evidence for an association between KIBRA and late-onset Alzheimer's disease.

Corneveaux JJ, Liang WS, Reiman EM, Webster JA, Myers AJ, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Craig DW, Coon KD, Dunckley T, Bandy D, Lee W, Chen K, Beach TG, Mastroeni D, Grover A, Ravid R, Sando SB, Aasly JO, Heun R, Jessen F, Kölsch H, Rogers J, Hutton ML, Melquist S, Petersen RC, Alexander GE, Caselli RJ, Papassotiropoulos A, Stephan DA, Huentelman MJ.

Neurobiol Aging. 2010 Jun;31(6):901-9. doi: 10.1016/j.neurobiolaging.2008.07.014. Epub 2008 Sep 13.

19.

A survey of genetic human cortical gene expression.

Myers AJ, Gibbs JR, Webster JA, Rohrer K, Zhao A, Marlowe L, Kaleem M, Leung D, Bryden L, Nath P, Zismann VL, Joshipura K, Huentelman MJ, Hu-Lince D, Coon KD, Craig DW, Pearson JV, Holmans P, Heward CB, Reiman EM, Stephan D, Hardy J.

Nat Genet. 2007 Dec;39(12):1494-9. Epub 2007 Nov 4.

PMID:
17982457
20.

Sorl1 as an Alzheimer's disease predisposition gene?

Webster JA, Myers AJ, Pearson JV, Craig DW, Hu-Lince D, Coon KD, Zismann VL, Beach T, Leung D, Bryden L, Halperin RF, Marlowe L, Kaleem M, Huentelman MJ, Joshipura K, Walker D, Heward CB, Ravid R, Rogers J, Papassotiropoulos A, Hardy J, Reiman EM, Stephan DA.

Neurodegener Dis. 2008;5(2):60-4. Epub 2007 Nov 1.

PMID:
17975299
Items per page

Supplemental Content

Loading ...
Write to the Help Desk